A Pilot Trial of Serial 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Medically Inoperable Stage I Non-Small-Cell Lung Cancer Treated With Hypofractionated Stereotactic Body Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 789-795

  Henderson, Mark A ^a   Hoopes, David J ^a,b   Fletcher, James W ^a   Lin, Pei Fen ^a   Tann, Mark ^a   Yiannoutsos, Constantin T ^a   Williams, Mark D ^c   Fakiris, Achilles J ^a   McGarry, Ronald C ^d   Timmerman, Robert D ^e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WRIGHT PATTERSON AIR FORCE BASE   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

18F fluorodeoxyglucose positron emission tomography; Body radiosurgery; Lung cancer; Non small cell lung cancer; Stereotactic body radiation therapy

Indexed keywords

18-F-FLUORODEOXYGLUCOSE; LUNG CANCER; NON SMALL CELL LUNG CANCER; RADIOSURGERY; STEREOTACTIC BODY RADIATION THERAPY;

BIOLOGICAL ORGANS; ELECTRONS; POSITRONS; RADIOTHERAPY; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRONCHITIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG UPTAKE; ERYTHEMA; ESOPHAGITIS; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PILOT STUDY; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION FIBROSIS; RADIATION INJURY; RADIATION PNEUMONIA; STEREOTACTIC BODY RADIATION THERAPY; SUBCUTANEOUS FIBROSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOSURGERY;

EID: 76049108779     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.051     Document Type: Article

References (33)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 (1995) 120-129
3. Adebonojo S.A., Bowser A.N., Moritz D.M., et al. Impact of revised stage classification of lung cancer on survival: a military experience. Chest 115 (1999) 1507-1513
4. Mountain C.F. A new international staging system for lung cancer. Chest 89 (1986) 225S-233S
5. Naruke T., Goya T., Tsuchiya R., et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96 (1988) 440-447
6. Gauden S., Ramsay J., and Tripcony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 108 (1995) 1278-1282
7. Armstrong J.G., and Minsky B.D. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 16 (1989) 247-255
8. Coy P., and Kennelly G.M. The role of curative radiotherapy in the treatment of lung cancer. Cancer 45 (1980) 698-702
9. Dosoretz D.E., Katin M.J., Blitzer P.H., et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 24 (1992) 3-9
10. Haffty B.G., Goldberg N.B., Gerstley J., et al. Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 15 (1988) 69-73
11. Kaskowitz L., Graham M.V., Emami B., et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27 (1993) 517-523
12. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
13. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
14. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
15. Fakiris A.J., McGarry R.C., Yiannoutsos C., et al. Stereotactic body radiation therapy for early-stage non-small cell lung carcinoma: Final results of Phase II study. Int J Radiat Oncol Biol Phys 72 (2008) S38-S38
16. Henderson M., McGarry R., Yiannoutsos C., et al. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 72 (2008) 404-409
17. Beitler J.J., Badine E.A., El-Sayah D., et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys 65 (2006) 100-106
18. Nagata Y., Negoro Y., Aoki T., et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52 (2002) 1041-1046
19. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
20. Nyman J., Johansson K.A., and Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer: Mature results for medically inoperable patients. Lung Cancer 51 (2006) 97-103
21. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 117-125
22. Choi N.C., Fischman A.J., Niemierko A., et al. Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1024-1035
23. Hicks R.J., Mac Manus M.P., Matthews J.P., et al. Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation. Int J Radiat Oncol Biol Phys 60 (2004) 412-418
24. Ichiya Y., Kuwabara Y., Sasaki M., et al. A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma. Ann Nucl Med 10 (1996) 193-200
25. Kubota K., Yamada S., Ishiwata K., et al. Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: A preliminary study. Eur J Nucl Med 20 (1993) 495-501
26. Kubota K., Yamada S., Ishiwata K., et al. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer. Clin Nucl Med 17 (1992) 877-881
27. Mac Manus M.P., Hicks R.J., Matthews J.P., et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 21 (2003) 1285-1292
28. Park C., Papiez L., Zhang S., et al. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 847-852
29. Timmerman R.D., and Story M. Stereotactic body radiation therapy: A treatment in need of basic biological research. Cancer J 12 (2006) 19-20
30. Ishimori T., Saga T., Nagata Y., et al. 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy. Ann Nucl Med 18 (2004) 669-674
31. Hoopes D.J., Tann M., Fletcher J.W., et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 56 (2007) 229-234
32. Coon D., Gokhale A.S., Burton S.A., et al. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: The role of positron emission tomography/computed tomography-based treatment planning. Clin Lung Cancer 9 (2008) 217-221
33. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839